Advanced Applications of Integrative Medicine for Mental Health Level 3

You’re eligible if you have completed:

Advanced Applications of Integrative Medicine for Mental Health – Level 2

There is no known commercial support or conflict of interest for this program. 



18 CE Credits for Psychologists, Social Workers, Marriage and Family Therapists, Professional Counselors, and Nurses are approved by The CE Company.

The CE Company is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. The CE Company maintains responsibility for this program and its content.

The CE Company has co-sponsored Advanced Applications of Integrative Medicine for Mental Health Level 3 for 18 continuing education (CE) credits to Psychologists, Social Workers, Nurses, Professional Counselors, and Marriage & Family Therapists in the following states:* 

Psychologists 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY 

Social Workers 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY 

Mental Health Counselors 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY 

Marriage and Family Therapists 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY

Nurses 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY 

Professional Counselors 
AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY 

*Participants should always check with their state’s licensure board regarding the acceptance of APA CE credits. If you are seeking continuing education credit for a specialty or location not listed above, it is your responsibility to contact your licensing/certification board to determine program eligibility. Partial credit for attendance of individual sessions is not available. 


Accessibility Policy: This program adheres to the standards of the Americans Disabilities Act. Please contact the Leslie Korn Institute for Integrative Medicine if special accommodation is required.

Grievances Policy: Leslie Korn Institute for Integrative Medicine seeks to ensure equitable treatment of every person and to make every attempt to resolve grievances in a fair manner. Please submit a written grievance to grievances_lkkim@protonmail.com. Grievances would receive, to the best of our ability, corrective action in order to prevent further problems.

Bland, J. S. (2019). What is evidence-based functional medicine in the 21st century? Integrative Medicine, 18(3): 14-18.

Calder, A. E., & Hasler, G. (2023). Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 48(1), 104–112. https://doi.org/10.1038/s41386-022-01389-z

Chey, W. D., Hashash, J. G., Manning, L., & Chang, L. (2022). AGA Clinical practice update on the role of diet in irritable bowel syndrome: Expert review. Gastroenterology 162, 1737-1745. https://doi.org/10.1053/j.gastro.2021.12.248

Dean, O., Giorlando, F., & Berk, M. (2011). N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action. Journal of Psychiatry and Neuroscience, 36(2), 78-86. DOI: 10.1503/jpn.100057  

Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021). The role of mitochondria in mood disorders: From physiology to pathophysiology and to treatment. Frontiers in Psychiatry, 12(546801). doi: 10.3389/fpsyt.2021.546801 

Green, J. E., Berk, M., Mohebbi, M., Loughman, A., McGuinness, A. J., Castle, D., Chatterton, M. L., Perez, J., Strandwitz, P., Athan, E., Hair, C., Nierenberg, A. A., Cryan, J. F., & Jacka, F. (2023). Feasibility, acceptability, and safety of faecal microbiota transplantation in the treatment of major depressive disorder: A pilot randomized controlled trial. The Canadian Journal of Psychiatry, 1-12. https://doi.org/10.1177/07067437221150508

Isaacs, L. L. (2021). Coffee enemas: A narrative review. Alternative Therapies, 27(3), 46-49.

Moncrieff, J., Cooper, R. E., Stockmann, T., Amendola, S., Hengartner, M. P., & Horowitz, M. A. (2022). The serotonin theory of depression: A systematic umbrella review of the evidence. Molecular psychiatry, 10.1038/s41380-022-01661-0. Advance online publication. https://doi.org/10.1038/s41380-022-01661-0

Novak, J. R., Robinson, L. P., & Korn, L. E. (2022). What MFTs should know about nutrition, psychosocial health, and collaborative care with nutrition professionals. Journal of Marital and Family Therapy, 48(2), 502–522. https://doi.org/10.1111/jmft.12540

Rao, R. V., Subramaniam, K. G., Gregory, J., Bredesen, A. L., Coward, C., Okada, S., Kelly, L., & Bredesen, D. E. (2023). Rationale for a multi-factorial approach for the reversal of cognitive decline in Alzheimer’s Disease and MCI: A review. International Journal of Molecular Sciences, 24(2), 1659. https://doi.org/10.3390/ijms24021659

Savulich, G., Hezemans, F. H., van Ghesel Grothe, S., Dafflon, J., Schulten, N., Brühl, A. B., Sahakian, B. J., & Robbins, T. W. (2019). Acute anxiety and autonomic arousal induced by CO2 inhalation impairs prefrontal executive functions in healthy humans. Translational Psychiatry, 9(1), 296. https://doi.org/10.1038/s41398-019-0634-z

1. Discuss the latest research and clinical application of the gut/brain axis and its relationship to anxiety and depression

2. Discuss the role of specific digestive disorders and their comorbidity in mental health

3. Apply the psychedelic readiness assessment to determine appropriate referrals

4. Discuss motivational interviewing  to enhance adherence to self-care plans

5. Apply the Brainbow blueprint fillable form to enhance motivation for adherence

6. Discuss 3 protocols for the reduction or elimination of medications

7. Discuss multifactorial influences on cognitive decline and Alzheimer’s

8. Discuss nutritional interventions to reduce the inflammatory process in depression

9. Describe endocannabinoid deficiency syndrome and proposed interventions

10. Describe an integrative approach to addressing addiction to benzodiazepines

11. Explain 3 lifestyle interventions used for medication withdrawal

12. Explain the best practices for irritable bowel syndrome and its relationship to mental health

13. Discuss the role for mental health clinicians in nutritional care and collaboration

14. Demonstrate expertise in the conduct of the Readiness to Taper assessment

15. Explain evidence-based Functional Medicine

16. Discuss the role of mitochondria in mood disorders

17. Describe the evidence for the serotonin theory of depression

18. Discuss the Bohr effect and its relationship to anxiety and breathing exercises

We can schedule one-on-one advanced coaching or clinical supervision sessions. You will get 100% of my time and attention. We’ll meet via Zoom.

Click here to download my process and fee sheet

If you add yourself to the waitlist, you will receive an invitation when the next course starts.

We will meet once a month for 90 minutes on Zoom. There will be 12 meetings, the course lasts for a year. 

Because this is an invitation-only, small-group program over 12 months there are no refunds following payment.